The Intergalactic Union Department of Health has announced a landmark medical achievement: the successful development of a universal vaccine for the common avian flu, a condition that has long affected avian citizens across multiple colonies.

This breakthrough was made possible through collaboration with human researchers from Earth, whose expertise in managing similar influenza strains — commonly referred to as “bird flu” — provided the foundation for adaptation. By refining human-developed vaccines with advanced Union biotechnology, scientists have created a treatment that is fully compatible with avian physiology while maintaining high efficacy.

Trial Results and Safety
Extensive clinical trials were conducted across four avian-majority colonies. Results confirm that the vaccine offers strong, long-lasting protection, with complications observed in only 0.00067% of test subjects. Union medical authorities have concluded that the vaccine poses negligible risk, far below the threshold for population-wide approval.

A Historic Milestone
Union Health Director Athen Vey released the following statement:
“This is more than a vaccine — it is proof of what collaboration between species can achieve. Humanity’s recent admission into the Union has already borne fruit, saving lives and strengthening the bonds of our shared destiny.”

Distribution has already begun, with priority shipments directed to colonies reporting the highest incidence of avian flu. The Department of Health encourages all eligible avian citizens to participate in local vaccination programs as they roll out over the coming cycles.

With this advancement, the Union takes one more step toward ensuring that no citizen, regardless of species, need suffer from preventable disease.